Consistent with this, a study conducted in India, which bears the highest burden of TB and multidrug-resistant TB (MDR-TB) globally, reported that among the tested isolates, 71.0% exhibited detectable mutations in the katG 315 region, while 29.0% exhibited mutations in the inhA promoter region [18]. This evidence concerns the gene INHA and tuberculosis.